"Executive Summary Hepatocellular Carcinoma Drugs Market: Share, Size & Strategic Insights CAGR Value The global hepatocellular carcinoma drugs market was valued at USD 1.21 billion in 2024 and is expected to reach USD 2.27 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.20%, primarily driven by...